The joumal uses Crossref ited-by service counts times cited of published aricles. Citedby allows Crossref members to find out who is citing their conten. This is the Citing Article List of “The transition from NAFLD to MASLD: implications for Diagnosis, Prognosis, and Clinical Management”.
|
No. |
Publication Date |
Citing Article |
|
1 |
2026 |
Roberto Vettor, Maria Letizia Petroni, Idit Dotan, Gadi Lalazar, Martin Haluzík, C. Wendy Spearman, Joel A. Dave, Faisal Abaalkhail, Salah Abusnana, Ali Alshehri, Radan Bruha, Mariann Harangi, Ahmad Jazzar, Michał Kukla, Shiva Kumar, Vaia Lambadiari, George Papatheodoridis, Mária Papp, Salvatore Petta, Corina Silvia Pop, Anca Pantea Stoian, Krzysztof Tomasiewicz. Overcoming the barriers in the screening, diagnosis, and follow-up of patients with metabolic dysfunction–associated steatotic liver disease (MASLD) and metabolic dysfunction–associated steatohepatitis (MASH), Reviews in Endocrine and Metabolic Disorders. 2026; 27: 213. https://doi.org/10.1007/s11154-026-10027-8 |
|
2 |
2025 |
Sina Bazmi, Mohammadreza Fardaei, Reza Homayounfar, Maryam Kazemi, Babak Pezeshki, Reza Malekzadeh, Nasrollah Ghahramani, Mojtaba Farjam. Cross-sectional and longitudinal associations between fatty liver index and kidney function using updated MASLD and CKD–EPI 2021 definitions: a population-based study with region-specific cutoffs, European Journal of Medical Research. 2025; 31: 42. https://doi.org/10.1186/s40001-025-03645-6 |
|
3 |
2026 |
Carlo Acierno, Marcello Orio, Luigi Schiavo, Angelo Saracino, Eugenio Stabile. From Metabolic Syndrome to Cardiovascular–Kidney–Metabolic Syndrome (CKM): A Clinical and Pathophysiological Continuum, Biomedicines. 2026; 14: 790. https://doi.org/10.3390/biomedicines14040790 |